Swedbank AB Has $255.86 Million Position in Veeva Systems Inc. $VEEV

Key Points

• Swedbank AB increased its stake in Veeva by 4.9% to 1,146,157 shares (about $255.86 million), representing roughly 0.70% ownership at the end of the quarter.
• Veeva reported a quarterly earnings beat (EPS $2.06 vs $1.94) and 16% revenue growth to $835.95M, while maintaining a $2.0B buyback; recent catalysts include S&P 500 inclusion and GenAI-related industry positioning supporting sentiment.
• Broker coverage is mixed — the consensus is a "Moderate Buy" with an average target of $278.70 amid several price-target cuts — and insider selling was disclosed (director sold 750 shares).

Swedbank AB boosted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 4.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,146,157 shares of the technology company's stock after buying an additional 53,982 shares during the quarter. Swedbank AB owned approximately 0.70% of Veeva Systems worth $255,857,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. GPS Wealth Strategies Group LLC increased its holdings in shares of Veeva Systems by 196.4% in the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company's stock valued at $25,000 after purchasing an additional 55 shares during the last quarter. Board of the Pension Protection Fund acquired a new stake in shares of Veeva Systems during the 4th quarter worth about $27,000. Raiffeisen Bank International AG acquired a new position in Veeva Systems in the 3rd quarter valued at about $28,000. Newbridge Financial Services Group Inc. raised its holdings in Veeva Systems by 322.6% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company's stock valued at $29,000 after acquiring an additional 100 shares during the period. Finally, Activest Wealth Management lifted its position in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company's stock worth $29,000 after acquiring an additional 127 shares during the last quarter. 88.20% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

VEEV has been the topic of several research reports. Truist Financial reaffirmed a "buy" rating and issued a $262.00 target price (down from $275.00) on shares of Veeva Systems in a research report on Thursday, March 5th. Royal Bank Of Canada dropped their price target on Veeva Systems from $330.00 to $275.00 and set an "outperform" rating for the company in a report on Thursday, March 5th. UBS Group upped their price objective on Veeva Systems from $200.00 to $220.00 and gave the company a "neutral" rating in a report on Thursday, March 5th. Wells Fargo & Company decreased their price target on shares of Veeva Systems from $333.00 to $317.00 and set an "overweight" rating on the stock in a research note on Thursday, March 5th. Finally, The Goldman Sachs Group started coverage on shares of Veeva Systems in a research report on Tuesday, January 13th. They set a "sell" rating and a $215.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $278.70.

Insider Buying and Selling

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total value of $116,730.00. Following the sale, the director owned 3,253 shares in the company, valued at $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.30% of the stock is currently owned by insiders.

Veeva Systems Stock Up 0.7%

Shares of VEEV stock opened at $171.44 on Wednesday. The business has a fifty day simple moving average of $174.52 and a 200 day simple moving average of $215.44. The company has a market cap of $28.00 billion, a P/E ratio of 31.69, a P/E/G ratio of 0.76 and a beta of 0.92. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The firm had revenue of $835.95 million during the quarter, compared to the consensus estimate of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The business's quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, equities research analysts anticipate that Veeva Systems Inc. will post 6.41 earnings per share for the current fiscal year.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: S&P 500 inclusion + management change — Veeva’s announced addition to the S&P 500 (effective May 7) and a reported general counsel transition sparked index-driven buying and a volume gap-up as ETFs and passive funds adjust holdings. Veeva Systems (VEEV) Is Up 6.9% After S&P 500 Addition and GC Transition News
• Positive Sentiment: GenAI / industry positioning — multiple industry write-ups flag Veeva as a beneficiary of rising GenAI adoption in healthcare workflows, supporting the growth narrative for its Vault platform and CRM suites. This thematic coverage attracts software-focused investors. Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell
• Positive Sentiment: Solid fundamentals and capital return — recent quarterly results showed an earnings beat and double-digit revenue growth; plus a $2.0B buyback program remains in place, which can support shares over time as buybacks reduce float. Veeva Systems Stock Page
• Neutral Sentiment: Brokerage coverage / analyst consensus — media pieces highlighting average broker recommendations and “Moderate Buy” consensus can amplify momentum but are not new fundamentals; analyst price targets remain wide. Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
• Neutral Sentiment: Repeat thematic coverage — additional Zacks / industry write-ups reiterate the GenAI tailwind; useful for sentiment but largely confirmatory rather than new catalysts. 3 Medical Info Systems Stocks Riding the GenAI Wave
• Negative Sentiment: Insider selling disclosed — Director Priscilla Hung sold 750 shares under a pre-arranged Rule 10b5‑1 plan. While routine, the sale can trigger short-term concern among some investors about insider conviction. Insider Selling: Veeva Systems Director Priscilla Hung Sells 750 Shares

About Veeva Systems

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.